Skip to main content
Top
Published in: The International Journal of Cardiovascular Imaging 7/2020

01-07-2020 | Echocardiography | Original Paper

Quantitative evaluation of subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus by three-dimensional echocardiography

Authors: Xiaoyan Chen, Haifeng Guo, Qingmei Yang, Jianxiu Fang, Xiaoyan Kang

Published in: The International Journal of Cardiovascular Imaging | Issue 7/2020

Login to get access

Abstract

Left ventricular (LV) function undergoes subtle changes (subclinical left ventricular dysfunction) in a large proportion of patients with type 2 diabetes (T2DM) who develop diabetic cardiomyopathy. This study aimed to quantify LV myocardial strain and synchrony in T2DM by real-time three-dimensional echocardiography (RT-3DE), and to evaluate subclinical LV dysfunction in T2DM at different glycemic control levels. Seventy-two patients with T2DM with an LV ejection fraction (LVEF) ≥ 55% and 45 healthy individuals as controls who underwent RT-3DE were studied. Patients were also subdivided into the DMa group (glycosylated hemoglobin < 7%, n = 38) and the DMb group (glycosylated hemoglobin ≥ 7%, n = 34). Three-dimensional strain and synchronization parameters of the left ventricle were measured by RT-3DE and compared among the three groups. Despite a similar LVEF, global longitudinal strain (GLS), global circumferential strain (GCS), and global area strain (GAS) in the DMb group were lower, and the standard deviation of peak time (Tm-SD) and the maximum difference in peak time (Tm-Dif) in the DMb group higher, than those in the control and DMa groups (all p < 0.05). Multivariable linear regression analysis showed that the duration of diabetes was independently associated with GCS (β =  − 0.516, p < 0.001) and GAS (β =  − 0.391, p = 0.005). HbA1c levels were independently associated with GLS (β =  − 0.675, p < 0.001), Tm-SD (β = 3.363, p < 0.001), and Tm-Dif (β = 3.895, p < 0.001). RT-3DE can detect subclinical myocardial dysfunction in poor glycemic control of T2DM, and myocardial dysfunction is associated with the duration of diabetes and HbA1c.
Literature
1.
go back to reference Tadic M, Ilic S, Cuspidi C, Stojcevski B, Ivanovic B, Bukarica L, Jozika L, Celic V (2015) Left ventricular mechanics in untreated normotensive patients with type 2 diabetes mellitus: a two- and three-dimensional speckle tracking study. Echocardiography 32(6):947–955CrossRef Tadic M, Ilic S, Cuspidi C, Stojcevski B, Ivanovic B, Bukarica L, Jozika L, Celic V (2015) Left ventricular mechanics in untreated normotensive patients with type 2 diabetes mellitus: a two- and three-dimensional speckle tracking study. Echocardiography 32(6):947–955CrossRef
2.
go back to reference Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 5:S1–85 Amos AF, McCarty DJ, Zimmet P (1997) The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 5:S1–85
3.
go back to reference Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213–3223CrossRef Boudina S, Abel ED (2007) Diabetic cardiomyopathy revisited. Circulation 115:3213–3223CrossRef
4.
go back to reference Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121:748–757CrossRef Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121:748–757CrossRef
5.
go back to reference Von Bibra H, St John Sutton M (2010) Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia 53:1033–1045CrossRef Von Bibra H, St John Sutton M (2010) Diastolic dysfunction in diabetes and the metabolic syndrome: promising potential for diagnosis and prognosis. Diabetologia 53:1033–1045CrossRef
6.
go back to reference Larghat AM, Swoboda PP, Biglands JD, Kearney MT, Greenwood JP, Plein S (2014) The microvascular efects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 15:1368–1376CrossRef Larghat AM, Swoboda PP, Biglands JD, Kearney MT, Greenwood JP, Plein S (2014) The microvascular efects of insulin resistance and diabetes on cardiac structure, function, and perfusion: a cardiovascular magnetic resonance study. Eur Heart J Cardiovasc Imaging 15:1368–1376CrossRef
7.
go back to reference Di Carli MF, Janisse J, Grunberger G, Ager J (2003) Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41:1387–1393CrossRef Di Carli MF, Janisse J, Grunberger G, Ager J (2003) Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41:1387–1393CrossRef
8.
go back to reference Luis SA, Yamada A, Khandheria BK, Speranza V, Benjamin A, Ischenko M, Platts DG, Hamilton-Craig CR, Haseler L, Burstow D et al (2014) Use of three-dimensional speckle-tracking echocardiography for quantitative assessment of global left ventricular function: a comparative study to three-dimensional echocardiography. J Am Soc Echocardiography 27:285–291CrossRef Luis SA, Yamada A, Khandheria BK, Speranza V, Benjamin A, Ischenko M, Platts DG, Hamilton-Craig CR, Haseler L, Burstow D et al (2014) Use of three-dimensional speckle-tracking echocardiography for quantitative assessment of global left ventricular function: a comparative study to three-dimensional echocardiography. J Am Soc Echocardiography 27:285–291CrossRef
9.
go back to reference Tops LF, Delgado V, Marsan NA, Bax JJ (2017) Myocardial strain to detect subtle left ventricular systolic dysfunction. Eur J Heart Fail 19(3):307–313CrossRef Tops LF, Delgado V, Marsan NA, Bax JJ (2017) Myocardial strain to detect subtle left ventricular systolic dysfunction. Eur J Heart Fail 19(3):307–313CrossRef
10.
go back to reference Ernande L, Bergerot C, Rietzschel ER, De Buyzere ML, Thibault H, Pignonblanc PG, Croisille P, Ovize M, Groisne L, Moulin P et al (2011) Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiography 24:1268–1275CrossRef Ernande L, Bergerot C, Rietzschel ER, De Buyzere ML, Thibault H, Pignonblanc PG, Croisille P, Ovize M, Groisne L, Moulin P et al (2011) Diastolic dysfunction in patients with type 2 diabetes mellitus: is it really the first marker of diabetic cardiomyopathy? J Am Soc Echocardiography 24:1268–1275CrossRef
11.
go back to reference Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S (2016) Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J 37:1196–1207CrossRef Smiseth OA, Torp H, Opdahl A, Haugaa KH, Urheim S (2016) Myocardial strain imaging: how useful is it in clinical decision making? Eur Heart J 37:1196–1207CrossRef
13.
go back to reference American Diabetes Association (2012) Standards of medical care in diabetes—2012. Diabetes Care 35(suppl):S11–63 American Diabetes Association (2012) Standards of medical care in diabetes—2012. Diabetes Care 35(suppl):S11–63
14.
go back to reference Nakai H, Takeuchi M, Nishikage T, Lang RM, Otsuji Y (2009) Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration. Eur J Echocardiogr 10:926–932CrossRef Nakai H, Takeuchi M, Nishikage T, Lang RM, Otsuji Y (2009) Subclinical left ventricular dysfunction in asymptomatic diabetic patients assessed by two-dimensional speckle tracking echocardiography: correlation with diabetic duration. Eur J Echocardiogr 10:926–932CrossRef
15.
go back to reference Ng AC, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Shanks M, Nucifora G, Smit JW, Diamant M, Romijn JA et al (2009) Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 104:1398–1401CrossRef Ng AC, Delgado V, Bertini M, van der Meer RW, Rijzewijk LJ, Shanks M, Nucifora G, Smit JW, Diamant M, Romijn JA et al (2009) Findings from left ventricular strain and strain rate imaging in asymptomatic patients with type 2 diabetes mellitus. Am J Cardiol 104:1398–1401CrossRef
16.
go back to reference Wang Q, Tan K, Xia H, Gao Y (2018) Left ventricular structural alterations are accompanied by subclinical systolic dysfunction in type 2 diabetes mellitus patients with concomitant hyperlipidemia: an analysis based on 3D speckle tracking echocardiography. Echocardiography 35:965–974CrossRef Wang Q, Tan K, Xia H, Gao Y (2018) Left ventricular structural alterations are accompanied by subclinical systolic dysfunction in type 2 diabetes mellitus patients with concomitant hyperlipidemia: an analysis based on 3D speckle tracking echocardiography. Echocardiography 35:965–974CrossRef
17.
go back to reference Li ZJ, Du LF, Luo XH (2014) Evaluation of ventricular-vascular coupling in patients with type 2 diabetes mellitus using 2-dimensional speckle tracking imaging. Huazhong Univ Sci Technolog Med Sci 34:929–934CrossRef Li ZJ, Du LF, Luo XH (2014) Evaluation of ventricular-vascular coupling in patients with type 2 diabetes mellitus using 2-dimensional speckle tracking imaging. Huazhong Univ Sci Technolog Med Sci 34:929–934CrossRef
18.
go back to reference Wang Q, Ma W, Xia J (2018) Nonalcoholic fatty liver is associated with further left ventricular abnormalities in patients with type 2 diabetes mellitus: a 3-dimensional speckle-tracking study. J Ultrasound Med 37:1899–1911CrossRef Wang Q, Ma W, Xia J (2018) Nonalcoholic fatty liver is associated with further left ventricular abnormalities in patients with type 2 diabetes mellitus: a 3-dimensional speckle-tracking study. J Ultrasound Med 37:1899–1911CrossRef
19.
go back to reference Truong VT, Phan HT, Pham KNP, Duong HNH, Ngo TNM, Palmer C et al (2019) Normal ranges of left ventricular strain by three-dimensional speckle-trackingechocardiography in adults: a systematic review and meta-analysis. J Am Soc Echocardiogr 32(12):1586–1597CrossRef Truong VT, Phan HT, Pham KNP, Duong HNH, Ngo TNM, Palmer C et al (2019) Normal ranges of left ventricular strain by three-dimensional speckle-trackingechocardiography in adults: a systematic review and meta-analysis. J Am Soc Echocardiogr 32(12):1586–1597CrossRef
20.
go back to reference Seo Y, Ishizu T, Aonuma K (2014) Current status of 3-dimensional speckle tracking echocardiography: a review from our experiences. J Cardiovasc Ultrasound 22:49–57CrossRef Seo Y, Ishizu T, Aonuma K (2014) Current status of 3-dimensional speckle tracking echocardiography: a review from our experiences. J Cardiovasc Ultrasound 22:49–57CrossRef
21.
go back to reference Xu TY, Sun JP, Lee AP, Yang XS, Qiao Z, Luo X et al (2014) Three-dimensional specklestrain echocardiography is more accurate and efficient than2Dstrain in the evaluation of left ventricular function. Int J Cardiol 176:360–366CrossRef Xu TY, Sun JP, Lee AP, Yang XS, Qiao Z, Luo X et al (2014) Three-dimensional specklestrain echocardiography is more accurate and efficient than2Dstrain in the evaluation of left ventricular function. Int J Cardiol 176:360–366CrossRef
22.
go back to reference Zhang X, Wei X, Liang Y, Liu M, Li C, Tang H (2013) Differential changes of left ventricular myocardial deformation in diabetic patients with controlled and uncontrolled blood glucose: a three-dimensional speckle-tracking echocardiography-based study. J Am Soc Echocardiogra 26:499–506CrossRef Zhang X, Wei X, Liang Y, Liu M, Li C, Tang H (2013) Differential changes of left ventricular myocardial deformation in diabetic patients with controlled and uncontrolled blood glucose: a three-dimensional speckle-tracking echocardiography-based study. J Am Soc Echocardiogra 26:499–506CrossRef
23.
go back to reference Yoshifumi S (2015) β-cell dysfunction: its critical role in prevention and management of type 2 diabetes. World J Diabetes 6(1):109–124CrossRef Yoshifumi S (2015) β-cell dysfunction: its critical role in prevention and management of type 2 diabetes. World J Diabetes 6(1):109–124CrossRef
25.
go back to reference Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103:2668–2673CrossRef Iribarren C, Karter AJ, Go AS, Ferrara A, Liu JY, Sidney S, Selby JV (2001) Glycemic control and heart failure among adult patients with diabetes. Circulation 103:2668–2673CrossRef
26.
go back to reference Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412CrossRef Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412CrossRef
28.
go back to reference Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P (2000) Myocardial cell death in human diabetes. Circ Res 87:1123–1132CrossRef Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P (2000) Myocardial cell death in human diabetes. Circ Res 87:1123–1132CrossRef
29.
go back to reference Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ (2006) Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48:1688–1697CrossRef Cai L, Wang Y, Zhou G, Chen T, Song Y, Li X, Kang YJ (2006) Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy. J Am Coll Cardiol 48:1688–1697CrossRef
30.
go back to reference Zhao XY, Hu SJ, Li J, Mou Y, Chen BP, Xia Q (2006) Decreased cardiac sarcoplasmic reticulum Ca2+-ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats. J Physiol Biochem 62:1–8CrossRef Zhao XY, Hu SJ, Li J, Mou Y, Chen BP, Xia Q (2006) Decreased cardiac sarcoplasmic reticulum Ca2+-ATPase activity contributes to cardiac dysfunction in streptozotocin-induced diabetic rats. J Physiol Biochem 62:1–8CrossRef
31.
go back to reference Taegtmeyer H, McNulty P, Young ME (2002) Adaptation and maladaptation of the heart in diabetes, part I. Circulation 105:1727–1733CrossRef Taegtmeyer H, McNulty P, Young ME (2002) Adaptation and maladaptation of the heart in diabetes, part I. Circulation 105:1727–1733CrossRef
32.
go back to reference An D, Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291:H1489–H1506CrossRef An D, Rodrigues B (2006) Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291:H1489–H1506CrossRef
Metadata
Title
Quantitative evaluation of subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus by three-dimensional echocardiography
Authors
Xiaoyan Chen
Haifeng Guo
Qingmei Yang
Jianxiu Fang
Xiaoyan Kang
Publication date
01-07-2020
Publisher
Springer Netherlands
Published in
The International Journal of Cardiovascular Imaging / Issue 7/2020
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-020-01833-5

Other articles of this Issue 7/2020

The International Journal of Cardiovascular Imaging 7/2020 Go to the issue